126 related articles for article (PubMed ID: 26727454)
1. High-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous system.
Curry RC; Faivre G; Akkari L; Joyce JA; Lin O; Rosenblum M; Diamond EL; Fisher R; Omuro A
Leuk Lymphoma; 2016 Aug; 57(8):1961-4. PubMed ID: 26727454
[No Abstract] [Full Text] [Related]
2. Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.
Moise L; Matta C; Hanna C; Pilorge S; Fermé C; Durrbach A; Ribrag V
Leuk Lymphoma; 2011 Mar; 52(3):521-4. PubMed ID: 21133726
[No Abstract] [Full Text] [Related]
3. Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone.
Becton DL; Kurtzberg J; Kinney TR; Friedman HS; Chaffee S; Falletta JM
Med Pediatr Oncol; 1987; 15(2):58-61. PubMed ID: 3108638
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.
Sun X; Liu J; Wang Y; Bai X; Chen Y; Qian J; Zhu H; Liu F; Qiu X; Sun S; Ji N; Liu Y
Oncotarget; 2017 Jul; 8(30):49156-49164. PubMed ID: 28467782
[TBL] [Abstract][Full Text] [Related]
5. Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.
Idbaih A; Mokhtari K; Emile JF; Galanaud D; Belaid H; de Bernard S; Benameur N; Barlog VC; Psimaras D; Donadieu J; Carpentier C; Martin-Duverneuil N; Haroche J; Feuvret L; Zahr N; Delattre JY; Hoang-Xuan K
Neurology; 2014 Oct; 83(16):1478-80. PubMed ID: 25209580
[No Abstract] [Full Text] [Related]
6. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.
Iwabuchi H; Kawashima H; Umezu H; Takachi T; Imamura M; Saitoh A; Ogose A; Imai C
Int J Hematol; 2017 Aug; 106(2):299-303. PubMed ID: 28247189
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
Heath JL; Burgett SE; Gaca AM; Jaffe R; Wechsler DS
Pediatr Blood Cancer; 2014 Oct; 61(10):1874-6. PubMed ID: 24888336
[TBL] [Abstract][Full Text] [Related]
8. Would you think of histiocytic sarcoma in this fine-needle aspiration?
Oliveira CC; Rocha JTQ; Silva GF; Biglia B; Gaiolla RD; Niero-Melo L; Domingues MAC
Ann Hematol; 2018 Nov; 97(11):2257-2259. PubMed ID: 29728735
[No Abstract] [Full Text] [Related]
9. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
10. Antemortem diagnosis of localized central nervous system histiocytic sarcoma in 2 dogs.
Tzipory L; Vernau KM; Sturges BK; Zabka TS; Highland MA; Petersen SA; Wisner ER; Moore PF; Vernau W
J Vet Intern Med; 2009; 23(2):369-74. PubMed ID: 19192150
[No Abstract] [Full Text] [Related]
11. Primary Orbital Histiocytic Sarcoma in a Child Successfully Treated With Multiagent Chemotherapy.
Mittal N; Aakalu V; Mehendele S; Setabutr P; Michals E; Schmidt ML
J Pediatr Hematol Oncol; 2016 Nov; 38(8):653-657. PubMed ID: 27467374
[TBL] [Abstract][Full Text] [Related]
12. Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
Voruz S; Cairoli A; Naveiras O; de Leval L; Missiaglia E; Homicsko K; Michielin O; Blum S
Haematologica; 2018 Jan; 103(1):e39-e41. PubMed ID: 29097496
[No Abstract] [Full Text] [Related]
13. Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.
Wang XX; Huang HQ; Bai B; Cai QQ; Cai QC; Gao Y; Xia YF; Xia ZJ; Jiang WQ
Leuk Lymphoma; 2014 Nov; 55(11):2497-501. PubMed ID: 24605911
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of idarubicin combined with methotrexate for treatment of patients with central nervous system diffuse large B cell lymphoma].
Yuan P; Yu ZP; Yue TH; Xiao YH; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1621-3. PubMed ID: 25543485
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
[TBL] [Abstract][Full Text] [Related]
16. A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
Olivier G; Clavert A; Lacotte-Thierry L; Gardembas M; Escoffre-Barbe M; Brion A; Cumin I; Legouffe E; Solal-Celigny P; Chabin M; Ingrand P; Colombat P; Delwail V
Am J Hematol; 2014 Nov; 89(11):1024-9. PubMed ID: 25052698
[TBL] [Abstract][Full Text] [Related]
17. [Malignant histiocytosis: study of 8 cases].
Fernández Miranda C; Martínez González MA; Ricard P; Ballestín C; Asso A; Hernández Martínez E; Guerra J; del Palacio A
Med Clin (Barc); 1988 Mar; 90(11):437-42. PubMed ID: 2455200
[No Abstract] [Full Text] [Related]
18. [Malignant histiocytosis. Remission for more than 5 years].
Lejeunne C; Degos L; Pol S; Hugues FC
Presse Med; 1990 Feb; 19(5):218. PubMed ID: 2137919
[No Abstract] [Full Text] [Related]
19. Etoposide-based combination chemotherapy in malignant histiocytosis.
Lin FR; Yao EG
J Tongji Med Univ; 1994; 14(4):227-9. PubMed ID: 7760434
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
Falchi L; Gunnellini M; Ferranti L; Liberati AM
Clin Neurol Neurosurg; 2012 Dec; 114(10):1376-8. PubMed ID: 22516417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
